Mr Mrs Miss Ms Dr Other

Dr
Jade
Cheng

Patent Attorney

London Office

Life sciences

Telephone. +44 (0)207 776 5100
Email. [email protected]

Experience

Jade joined the Life Sciences group of HGF in February 2022 as a qualified UK and European Patent Attorney.

Prior to being a Patent Attorney, Jade was a postdoctoral fellow at the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge. During her time as an academic, she investigated diverse subjects including the blood brain barrier, mechanisms of cell death and embryonic development.

Jade’s experience in academia means she understands the patenting process from academics' point of view and is ideally placed to work alongside universities’ technology transfer departments and their academics.

Jade’s main areas of focus in patent practice are on antibodies, vaccines and medical treatments. She has experience with drafting and filing applications, prosecution, freedom-to-operate analyses, third party observations, EPO oppositions and appeals, and providing filing strategies. She also advises clients on prosecution in many foreign jurisdictions.

Jade enjoys being a member of the HGF Venture team with Kerry Rees to provide IP due diligence services to life science investors. As a consequence, Jade also works with early stage companies to help them align their IP strategies with their business plan to maximum the return on investment.

Jade is fluent in English and Cantonese.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Biochemistry

PHD

Biochemistry

Related News

The UPC has opened its doors! See the latest updates and advice on the UPC here.

The European patent system has had the biggest change in a generation – on 1 June 2023 the Unified Patent Court (UPC) and a new “unitary patent” or “European patent …

Read article

Managing Intellectual Property IP Stars 2023

After months of research, Managing IP has published the IP Stars list for 2023. HGF is delighted to have 23 attorneys from England, Scotland, Ireland, Netherlands and Germany recognised and …

Read article

Profiting from Innovation Within Product Platforms

Innovative businesses should seek to maximise the value they obtain from working collaboratively within a product platform ecosystem. A well-defined IP strategy can help achieve this while increasing total innovation …

Read article
Event - 25th May 2023

New seminar series in Salzburg, Dresden and Hamburg

HGF is organising a new German-speaking seminar series in Salzburg, Dresden, and Hamburg starting May 25 2023. Dates May 25, 2023 at 17:30 – Salzburg June 1 2023 at 17:30 …

Event details

Can Artificial Intelligence save the NHS?

In recent months, it has been almost impossible to escape reports of the staffing crisis in the NHS and the impact this is having on the services the NHS can …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.